152 related articles for article (PubMed ID: 23377630)
1. The CAINS: theoretical and practical advances in the assessment of negative symptoms in schizophrenia.
Barch DM
Am J Psychiatry; 2013 Feb; 170(2):133-5. PubMed ID: 23377630
[No Abstract] [Full Text] [Related]
2. The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.
Kring AM; Gur RE; Blanchard JJ; Horan WP; Reise SP
Am J Psychiatry; 2013 Feb; 170(2):165-72. PubMed ID: 23377637
[TBL] [Abstract][Full Text] [Related]
3. Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
Forbes C; Blanchard JJ; Bennett M; Horan WP; Kring A; Gur R
Schizophr Res; 2010 Dec; 124(1-3):36-42. PubMed ID: 20869848
[TBL] [Abstract][Full Text] [Related]
4. Examining the reliability and validity of the Clinical Assessment Interview for Negative Symptoms within the Management of Schizophrenia in Clinical Practice (MOSAIC) multisite national study.
Blanchard JJ; Bradshaw KR; Garcia CP; Nasrallah HA; Harvey PD; Casey D; Csoboth CT; Hudson JI; Julian L; Lentz E; Nuechterlein KH; Perkins DO; Skale TG; Snowden LR; Tandon R; Tek C; Velligan D; Vinogradov S; O'Gorman C
Schizophr Res; 2017 Jul; 185():137-143. PubMed ID: 28087270
[TBL] [Abstract][Full Text] [Related]
5. Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).
Valiente-Gómez A; Mezquida G; Romaguera A; Vilardebò I; Andrés H; Granados B; Larrubia J; Pomarol-Clotet E; McKenna PJ; Sarró S; Bernardo M
Schizophr Res; 2015 Aug; 166(1-3):104-9. PubMed ID: 26116328
[TBL] [Abstract][Full Text] [Related]
6. Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.
Xie DJ; Shi HS; Lui SSY; Shi C; Li Y; Ho KKY; Hung KSY; Li WX; Yi ZH; Cheung EFC; Kring AM; Chan RCK
Schizophr Bull; 2018 Oct; 44(suppl_2):S547-S555. PubMed ID: 29471331
[TBL] [Abstract][Full Text] [Related]
7. Evidence for two distinct domains of negative symptoms: Confirming the factorial structure of the CAINS.
Richter J; Hesse K; Schreiber L; Burmeister CP; Eberle MC; Eckstein KN; Zimmermann L; Wildgruber D; Klingberg S
Psychiatry Res; 2019 Jan; 271():693-701. PubMed ID: 30791343
[TBL] [Abstract][Full Text] [Related]
8. Clinical picture, pathogenesis and psychometric assessment of negative symptoms of schizophrenia.
Wójciak P; Rybakowski J
Psychiatr Pol; 2018 Apr; 52(2):185-197. PubMed ID: 29975360
[TBL] [Abstract][Full Text] [Related]
9. Screening for negative symptoms: preliminary results from the self-report version of the Clinical Assessment Interview for Negative Symptoms.
Park SG; Llerena K; McCarthy JM; Couture SM; Bennett ME; Blanchard JJ
Schizophr Res; 2012 Mar; 135(1-3):139-43. PubMed ID: 22265640
[TBL] [Abstract][Full Text] [Related]
10. Behavioural Observation Schedule (BOS), PIRS 2nd edition. A revised edition of the PIRS (WHO, Geneva, March 1978).
Atakan Z; Cooper JE
Br J Psychiatry Suppl; 1989 Nov; (7):78-88. PubMed ID: 2619985
[No Abstract] [Full Text] [Related]
11. Measurement of negative and depressive symptoms: Discriminatory relevance of affect and expression.
Richter J; Hölz L; Hesse K; Wildgruber D; Klingberg S
Eur Psychiatry; 2019 Jan; 55():23-28. PubMed ID: 30384108
[TBL] [Abstract][Full Text] [Related]
12. Revisiting the persistent negative symptoms proxy score using the Clinical Assessment Interview for Negative Symptoms.
Li Y; Li WX; Zou YM; Yang ZY; Xie DJ; Yang Y; Lui SSY; Strauss GP; Cheung EFC; Chan RCK
Schizophr Res; 2018 Dec; 202():248-253. PubMed ID: 29996973
[TBL] [Abstract][Full Text] [Related]
13. [Scale for assessing negative symptoms in schizophrenia: A systematic review].
Mach C; Dollfus S
Encephale; 2016 Apr; 42(2):165-71. PubMed ID: 26923997
[TBL] [Abstract][Full Text] [Related]
14. Anhedonia and schizophrenia.
Harrow M; Grinker RR; Holzman PS; Kayton L
Am J Psychiatry; 1977 Jul; 134(7):794-7. PubMed ID: 869058
[TBL] [Abstract][Full Text] [Related]
15. Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).
Horan WP; Kring AM; Gur RE; Reise SP; Blanchard JJ
Schizophr Res; 2011 Nov; 132(2-3):140-5. PubMed ID: 21798716
[TBL] [Abstract][Full Text] [Related]
16. Issues in selection of instruments to measure negative symptoms.
Daniel DG
Schizophr Res; 2013 Nov; 150(2-3):343-5. PubMed ID: 23899996
[TBL] [Abstract][Full Text] [Related]
17. Self-assessment of negative symptoms - Critical appraisal of the motivation and pleasure - Self-report's (MAP-SR) validity and reliability.
Richter J; Hesse K; Eberle MC; Eckstein KN; Zimmermann L; Schreiber L; Burmeister CP; Wildgruber D; Klingberg S
Compr Psychiatry; 2019 Jan; 88():22-28. PubMed ID: 30466014
[TBL] [Abstract][Full Text] [Related]
18. [Anhedonia in schizophrenia].
Loas G; Boyer P; Legrand A; Gayant C; Delahousse J
Encephale; 1995; 21(6):453-7. PubMed ID: 8674470
[TBL] [Abstract][Full Text] [Related]
19. [Prodromal symptoms in schizophrenic relapse: A descriptive and comparative study].
Bouhlel S; Jones Y; Khelifa E; Msolly M; Melki W; El-Hechmi Z
Encephale; 2012 Oct; 38(5):397-403. PubMed ID: 23062453
[TBL] [Abstract][Full Text] [Related]
20. Social affiliation and negative symptoms in schizophrenia: Examining the role of behavioral skills and subjective responding.
Blanchard JJ; Park SG; Catalano LT; Bennett ME
Schizophr Res; 2015 Oct; 168(1-2):491-7. PubMed ID: 26235753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
